{
    "type": "ETF",
    "ucits": true,
    "fund_name": "iShares iBonds Dec 2028 Term \u20ac CorpEUR (Acc) Share Class",
    "replication_method": "physical",
    "leverage": false,
    "derivatives": false,
    "swaps": false,
    "inverse": false,
    "complex_factors": "",
    "classification": "non-complex",
    "supporting_data": "The Fund is a UCITS ETF physically replicating the Bloomberg MSCI December 2028 Maturity EUR Corporate ESG Screened Index by investing directly in fixed income securities (investment grade, Euro denominated corporate bonds maturing in 2028). The KIID and PRIIPs KID confirm the Fund uses physical replication with sampled methodology and only uses financial derivative instruments (FDIs) for direct investment purposes, not as an inherent part of the strategy, implying derivatives are used for risk management rather than synthetic replication. There is no mention of swap agreements, total return swaps, or synthetic replication structures. The Fund does not employ leverage, inverse or amplified exposure. The risk profile is moderate to low (risk rating 4 in KIID, 2 in PRIIPs KID), consistent with a straightforward bond ETF. The Fund engages in short-term securities lending, but this does not increase complexity under MiFID II. The underlying assets are investment grade corporate bonds, liquid and transparent, with no contingent convertible bonds or complex structured products. No capital protection or structured features are present. Counterparty risk disclosures relate to normal custody and securities lending counterparties, not to synthetic swap counterparties. Costs are simple with a low ongoing charge (0.12%) and no performance fees or swap fees. The monthly factsheet confirms physical sampled replication and no use of swaps or leverage. The ESG screening and index construction do not add complexity under MiFID II. There is no PRIIPs comprehension warning or other complexity flags. Therefore, the Fund is classified as non-complex under MiFID II."
}